Plixorafenib — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-27 in 5d
ESTIMATED |
READOUT
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cance
Phase 2 · Cancer Harboring BRAF Alterations, HGG |
Fore Biotherapeutics | Plixorafenib |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|